Canada markets open in 3 hours 11 minutes

InnoCan Pharma Corporation (IP4.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
0.1855+0.0010 (+0.54%)
As of 09:59AM CEST. Market open.
Currency in EUR

Valuation Measures4

Market Cap (intraday) 52.62M
Enterprise Value 49.02M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)3.71
Price/Book (mrq)13.50
Enterprise Value/Revenue 3.59
Enterprise Value/EBITDA -12.25

Trading Information

Stock Price History

Beta (5Y Monthly) 3.07
52-Week Change 318.01%
S&P500 52-Week Change 321.08%
52 Week High 30.3500
52 Week Low 30.1204
50-Day Moving Average 30.2036
200-Day Moving Average 30.2086

Share Statistics

Avg Vol (3 month) 344.37k
Avg Vol (10 day) 364.79k
Shares Outstanding 5280.66M
Implied Shares Outstanding 6285.19M
Float 8216.17M
% Held by Insiders 113.91%
% Held by Institutions 10.19%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Currency in USD.

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin -34.42%
Operating Margin (ttm)-18.27%

Management Effectiveness

Return on Assets (ttm)-34.16%
Return on Equity (ttm)-80.07%

Income Statement

Revenue (ttm)13.66M
Revenue Per Share (ttm)0.05
Quarterly Revenue Growth (yoy)331.10%
Gross Profit (ttm)N/A
EBITDA -3.77M
Net Income Avi to Common (ttm)-4.7M
Diluted EPS (ttm)-0.0200
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)3.88M
Total Cash Per Share (mrq)0.01
Total Debt (mrq)33k
Total Debt/Equity (mrq)0.75%
Current Ratio (mrq)2.68
Book Value Per Share (mrq)0.01

Cash Flow Statement

Operating Cash Flow (ttm)-3.9M
Levered Free Cash Flow (ttm)-719.88k